142 related articles for article (PubMed ID: 35074512)
21. ODAM promotes junctional epithelium-related gene expression via activation of WNT1 signaling pathway in an ameloblast-like cell line ALC.
Song D; Yang S; Tan T; Wang R; Ma Z; Wang Y; Wang L
J Periodontal Res; 2021 Jun; 56(3):482-491. PubMed ID: 33452817
[TBL] [Abstract][Full Text] [Related]
22. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.
Ren Y; Guo L; Tang X; Apparsundaram S; Kitson C; Deguzman J; Fuentes ME; Coyle L; Majmudar R; Allard J; Truitt T; Hamid R; Chen Y; Qian Y; Budd DC
Microvasc Res; 2013 Jan; 85():59-67. PubMed ID: 23084965
[TBL] [Abstract][Full Text] [Related]
23. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling.
Weiner JA; Fukushima N; Contos JJ; Scherer SS; Chun J
J Neurosci; 2001 Sep; 21(18):7069-78. PubMed ID: 11549717
[TBL] [Abstract][Full Text] [Related]
24. LPA
Suckau O; Gross I; Schrötter S; Yang F; Luo J; Wree A; Chun J; Baska D; Baumgart J; Kano K; Aoki J; Bräuer AU
Dev Dyn; 2019 May; 248(5):375-395. PubMed ID: 30847983
[TBL] [Abstract][Full Text] [Related]
25. Critical role for αvβ6 integrin in enamel biomineralization.
Mohazab L; Koivisto L; Jiang G; Kytömäki L; Haapasalo M; Owen GR; Wiebe C; Xie Y; Heikinheimo K; Yoshida T; Smith CE; Heino J; Häkkinen L; McKee MD; Larjava H
J Cell Sci; 2013 Feb; 126(Pt 3):732-44. PubMed ID: 23264742
[TBL] [Abstract][Full Text] [Related]
26. LPA
Lin YC; Chen CC; Chen WM; Lu KY; Shen TL; Jou YC; Shen CH; Ohbayashi N; Kanaho Y; Huang YL; Lee H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1305-1315. PubMed ID: 30053596
[TBL] [Abstract][Full Text] [Related]
27. E-cadherin can replace N-cadherin during secretory-stage enamel development.
Guan X; Bidlack FB; Stokes N; Bartlett JD
PLoS One; 2014; 9(7):e102153. PubMed ID: 25014356
[TBL] [Abstract][Full Text] [Related]
28. Dental enamel structure is altered by expression of dominant negative RhoA in ameloblasts.
Li Y; Pugach MK; Kuehl MA; Peng L; Bouchard J; Hwang SY; Gibson CW
Cells Tissues Organs; 2011; 194(2-4):227-31. PubMed ID: 21576911
[TBL] [Abstract][Full Text] [Related]
29. LPA
Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
[TBL] [Abstract][Full Text] [Related]
30. Differential anatomical and cellular expression of lysophosphatidic acid receptor 1 in adult mouse brain.
Kajitani N; Okada-Tsuchioka M; Kano K; Omori W; Boku S; Aoki J; Takebayashi M
Biochem Biophys Res Commun; 2020 Oct; 531(2):89-95. PubMed ID: 32718668
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acid (LPA) receptor-mediated signaling and cellular responses to anticancer drugs and radiation of cancer cells.
Ikeda H; Takai M; Tsujiuchi T
Adv Biol Regul; 2024 May; 92():101029. PubMed ID: 38377635
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice.
López-Serrano C; Santos-Nogueira E; Francos-Quijorna I; Coll-Miró M; Chun J; López-Vales R
Brain Behav Immun; 2019 Feb; 76():258-267. PubMed ID: 30550929
[TBL] [Abstract][Full Text] [Related]
33. Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells.
Kim EK; Park JM; Lim S; Choi JW; Kim HS; Seok H; Seo JK; Oh K; Lee DS; Kim KT; Ryu SH; Suh PG
J Biol Chem; 2011 Jul; 286(27):24036-45. PubMed ID: 21602274
[TBL] [Abstract][Full Text] [Related]
34. LPP3 localizes LPA6 signalling to non-contact sites in endothelial cells.
Yukiura H; Kano K; Kise R; Inoue A; Aoki J
J Cell Sci; 2015 Nov; 128(21):3871-7. PubMed ID: 26345369
[TBL] [Abstract][Full Text] [Related]
35. Effects of LPA
Takahashi K; Fukushima K; Otagaki S; Ishimoto K; Minami K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Feb; 38(1):71-75. PubMed ID: 29369010
[TBL] [Abstract][Full Text] [Related]
36. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.
Gennero I; Laurencin-Dalicieux S; Conte-Auriol F; Briand-Mésange F; Laurencin D; Rue J; Beton N; Malet N; Mus M; Tokumura A; Bourin P; Vico L; Brunel G; Oreffo RO; Chun J; Salles JP
Bone; 2011 Sep; 49(3):395-403. PubMed ID: 21569876
[TBL] [Abstract][Full Text] [Related]
37. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
[TBL] [Abstract][Full Text] [Related]
38. Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction.
Kranenburg O; Poland M; van Horck FP; Drechsel D; Hall A; Moolenaar WH
Mol Biol Cell; 1999 Jun; 10(6):1851-7. PubMed ID: 10359601
[TBL] [Abstract][Full Text] [Related]
39. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
40. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1.
Van Leeuwen FN; Olivo C; Grivell S; Giepmans BN; Collard JG; Moolenaar WH
J Biol Chem; 2003 Jan; 278(1):400-6. PubMed ID: 12393875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
